HBIO harvardbioscience.com: Company Value to Revenue

Official company branding of Harvard Bioscience (HBIO)

Harvard Bioscience maintains an impeccable reputation as a global leader in the biomedical equipment sector. The company develops advanced microfluidic chips and organ-on-a-chip systems for pharmacology. Stable demand for consumables provides the business with a reliable cash flow. The EV/Sales valuation demonstrates debt-free value dynamics, where 885.02 expresses the current level of the metric.

Harvard Bioscience Inc. (HBIO): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

HBIO (harvardbioscience.com): analytical breakdowns and indicator data

- current quotes and average value forecast:
Fundamental company valuation:Harvard Bioscience HBIO
Manufactured products of Harvard Bioscience

This indicator measures the enterprise value, including debt and excluding cash, relative to annual sales to determine the asset's market overvaluation. By analyzing the EV/Sales valuation of Harvard Bioscience (HBIO) on the GURU.Markets platform, an investor can see how the premium positioning of Harvard Bioscience (HBIO) in the electrophysiology segment and the loyalty of the scientific community support a high enterprise value relative to generated revenue.

Competitor analysis for Harvard Bioscience

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|EV/Sales Multiple KRMD|Total Company Value-to-Revenue Ratio Nyxoah, S.A.|Microbot Medical Inc - Company Value to Revenue|Total Company Value-to-Revenue Ratio Pro-Dex Inc. (PDEX)|Zentek - EV/Sales Multiple|Elutia (ELUT) - Company Value to Revenue|Milestone Scientific Inc (MLSS) - Enterprise Value-to-Revenue Ratio|NXGL - Total Company Value-to-Revenue Ratio|Company Value to Revenue RVP|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple